American Century Companies’s Fulgent Genetics FLGT Stock Holding History

American Century Companies’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$793K	Sell	38,649 -15,292	-28%	-$259K	﹤0.01%	2477
2026 Q1	$858K	Sell	53,941 -790	-1%	-$17.1K	﹤0.01%	2372
2025 Q4	$1.44M	Sell	54,731 -3,925	-7%	-$102K	﹤0.01%	2205
2025 Q3	$1.33M	Buy	58,656 +6,488	+12%	+$134K	﹤0.01%	2207
2025 Q2	$1.04M	Buy	52,168 +3,860	+8%	+$75.2K	﹤0.01%	2280
2025 Q1	$816K	Buy	48,308 +2,663	+6%	+$45.4K	﹤0.01%	2320
2024 Q4	$843K	Buy	45,645 +4,262	+10%	+$83.2K	﹤0.01%	2317
2024 Q3	$899K	Buy	41,383 +5,804	+16%	+$130K	﹤0.01%	2275
2024 Q2	$698K	Buy	35,579 +4,088	+13%	+$85.3K	﹤0.01%	2318
2024 Q1	$683K	Sell	31,491 -3,646	-10%	-$90.5K	﹤0.01%	2307
2023 Q4	$1.02M	Sell	35,137 -221,073	-86%	-$5.92M	﹤0.01%	2053
2023 Q3	$6.85M	Sell	256,210 -16,061	-6%	-$548K	0.01%	1217
2023 Q2	$10.1M	Sell	272,271 -6,081	-2%	-$212K	0.01%	1047
2023 Q1	$8.69M	Buy	278,352 +39,185	+16%	+$1.26M	0.01%	1069
2022 Q4	$7.12M	Buy	239,167 +47,842	+25%	+$1.71M	0.01%	1091
2022 Q3	$7.29M	Buy	191,325 +31,726	+20%	+$1.59M	0.01%	996
2022 Q2	$8.7M	Buy	159,599 +33,035	+26%	+$1.82M	0.01%	948
2022 Q1	$7.9M	Buy	126,564 +26,881	+27%	+$1.77M	0.01%	984
2021 Q4	$10M	Buy	99,683 +40,846	+69%	+$3.59M	0.01%	882
2021 Q3	$5.29M	Buy	58,837 +46,038	+360%	+$4.18M	﹤0.01%	1017
2021 Q2	$1.18M	Buy	12,799 +10,357	+424%	+$827K	﹤0.01%	1475
2021 Q1	$236K	Buy	+2,442	New	+$252K	﹤0.01%	2028

Other funds holding FLGT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

SSP

Sixth Street Partners Dallas, Texas $751B AUM 15.65% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

American Century Companies's FLGT Position: Q2 2026 in Review

American Century Companies reduced its Fulgent Genetics (FLGT) stake by 28% in Q2 2026, selling an estimated $259K and leaving 38,649 shares worth $793K. The position accounts for ﹤0.01% of the portfolio, ranked #2477.

American Century Companies first reported a position in FLGT in Q1 2021 and has held it in 22 quarters since. The position peaked at $10.1M in Q2 2023. 107 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

American Century Companies held 38,649 shares of Fulgent Genetics worth $793K as of Q2 2026.
American Century Companies sold 15,292 Fulgent Genetics shares in Q2 2026, an estimated $259K.
Fulgent Genetics made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2477 holding.
American Century Companies first reported a position in Fulgent Genetics in Q1 2021 and has held it in 22 quarters since.
American Century Companies's Fulgent Genetics position peaked at $10.1M in Q2 2023.
107 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.